The COPERNICUS research study
Learn about this study for adults with non-small cell lung cancer (NSCLC) that has spread.
This study is for adults 18 years of age or older who have been diagnosed with advanced or metastatic NSCLC and have a specific mutation in the epidermal growth factor receptor (EGFR) gene.
You can join the study if you:
- Are 18 years of age or older
- Have been diagnosed with advanced or metastatic NSCLC
- Have a specific mutation in the EGFR gene
Additional eligibility criteria will apply.
You cannot join the study if you:
- Have a history of uncontrolled illness
- Have a history of active interstitial lung disease (ILD)
- Have a history of significant cardiovascular disease (eg: congestive heart failure)
Additional eligibility criteria will apply.
- In order to join this study, patients must go through a screening process and meet all eligibility criteria
- Eligible patients will be placed based on an investigational medication + oral study medication
- Participants will know the investigational medication combination they are receiving
- Study medication will be given in recurring 28 day cycles
- At study visits, participants will have their health evaluated through various health exams and tests study
- Participation may last up to 3 years, if the participant wants to continue and the study doctor believes it's safe
- Patients may receive benefit from participation in the study but that is not guaranteed
- Study participation may help researchers learn more about NSCLC and the investigational medicine
- Participants could experience one or more side effects during the study
- Some potential side effects are noted below
- During the study participants will be closely monitored for any side effects and changes in their health
- Participants will be instructed on how to manage the potential side effects, such as skin rash, through the use of a lotion, moisturizer, solution, and antibiotic
See if you may qualify
Answer the following questions to see if you or someone you know may be eligible to take part in this study.
Please keep in mind:
Even if you believe you meet the eligibility criteria, joining a clinical trial is not guaranteed. Whether you’re referred or able to take part depends on a review by a qualified healthcare professional.
About your information:
With your consent, we will use your answers to help determine whether you may be eligible for this clinical trial. You can withdraw your consent at any time.
Your information may be transferred to countries outside your country of residence, including the United States, which may have different data protection rules.
If you submit any personal information about someone else, you confirm that you have permission to do so.
Please read our Privacy policy for more details.